These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26046928)

  • 21. Feeding Releases Endogenous Opioids in Humans.
    Tuulari JJ; Tuominen L; de Boer FE; Hirvonen J; Helin S; Nuutila P; Nummenmaa L
    J Neurosci; 2017 Aug; 37(34):8284-8291. PubMed ID: 28747384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced mu opioid receptor availability in schizophrenia revealed with [
    Ashok AH; Myers J; Reis Marques T; Rabiner EA; Howes OD
    Nat Commun; 2019 Oct; 10(1):4493. PubMed ID: 31582737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity is associated with decreased μ-opioid but unaltered dopamine D2 receptor availability in the brain.
    Karlsson HK; Tuominen L; Tuulari JJ; Hirvonen J; Parkkola R; Helin S; Salminen P; Nuutila P; Nummenmaa L
    J Neurosci; 2015 Mar; 35(9):3959-65. PubMed ID: 25740524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.
    Weerts EM; Wand GS; Kuwabara H; Munro CA; Dannals RF; Hilton J; Frost JJ; McCaul ME
    Alcohol Clin Exp Res; 2011 Dec; 35(12):2162-73. PubMed ID: 21689118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety.
    Nummenmaa L; Karjalainen T; Isojärvi J; Kantonen T; Tuisku J; Kaasinen V; Joutsa J; Nuutila P; Kalliokoski K; Hirvonen J; Hietala J; Rinne J
    Neuropsychopharmacology; 2020 Oct; 45(11):1953-1959. PubMed ID: 32473595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.
    Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF
    Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis.
    Hermann D; Hirth N; Reimold M; Batra A; Smolka MN; Hoffmann S; Kiefer F; Noori HR; Sommer WH; Reischl G; la Fougère C; Mann K; Spanagel R; Hansson AC
    Neuropsychopharmacology; 2017 Feb; 42(3):606-614. PubMed ID: 27510425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder.
    Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Walker SJ; Mickey BJ; Koeppe RA; Langenecker SA; Zubieta JK
    Mol Psychiatry; 2015 Feb; 20(2):193-200. PubMed ID: 25600108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.
    Johansson J; Hirvonen J; Lovró Z; Ekblad L; Kaasinen V; Rajasilta O; Helin S; Tuisku J; Sirén S; Pennanen M; Agrawal A; Crystal R; Vainio PJ; Alho H; Scheinin M
    Neuropsychopharmacology; 2019 Aug; 44(9):1667-1673. PubMed ID: 30867551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of [
    Kelleher AC; Pearson TD; Ramsey J; Zhao W; O'Conor KA; Bakhoda A; Stodden T; Guo M; Eisenberg SM; Shah SV; Freaney ML; Kim W; Kang Y; Tomasi D; Johnson C; Fang CA; Volkow ND; Kim SW
    Sci Rep; 2024 Jul; 14(1):16250. PubMed ID: 39009645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aerobic exercise modulates anticipatory reward processing via the μ-opioid receptor system.
    Saanijoki T; Nummenmaa L; Tuulari JJ; Tuominen L; Arponen E; Kalliokoski KK; Hirvonen J
    Hum Brain Mapp; 2018 Oct; 39(10):3972-3983. PubMed ID: 29885086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reaching out for Sensitive Evaluation of the Mu Opioid Receptor in Vivo: Positron Emission Tomography Imaging of the Agonist [
    Rafique W; Khanapur S; Spilhaug MM; Riss PJ
    ACS Chem Neurosci; 2017 Sep; 8(9):1847-1852. PubMed ID: 28590714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients.
    Ghitza UE; Preston KL; Epstein DH; Kuwabara H; Endres CJ; Bencherif B; Boyd SJ; Copersino ML; Frost JJ; Gorelick DA
    Biol Psychiatry; 2010 Oct; 68(8):697-703. PubMed ID: 20579973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief.
    Falcone M; Gold AB; Wileyto EP; Ray R; Ruparel K; Newberg A; Dubroff J; Logan J; Zubieta JK; Blendy JA; Lerman C
    Psychopharmacology (Berl); 2012 Aug; 222(4):701-8. PubMed ID: 22389047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid Release after High-Intensity Interval Training in Healthy Human Subjects.
    Saanijoki T; Tuominen L; Tuulari JJ; Nummenmaa L; Arponen E; Kalliokoski K; Hirvonen J
    Neuropsychopharmacology; 2018 Jan; 43(2):246-254. PubMed ID: 28722022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission.
    Zubieta JK; Ketter TA; Bueller JA; Xu Y; Kilbourn MR; Young EA; Koeppe RA
    Arch Gen Psychiatry; 2003 Nov; 60(11):1145-53. PubMed ID: 14609890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems.
    Tuominen L; Nummenmaa L; Keltikangas-Järvinen L; Raitakari O; Hietala J
    Hum Brain Mapp; 2014 May; 35(5):1875-84. PubMed ID: 23671038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence.
    Bencherif B; Wand GS; McCaul ME; Kim YK; Ilgin N; Dannals RF; Frost JJ
    Biol Psychiatry; 2004 Feb; 55(3):255-62. PubMed ID: 14744466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report.
    DosSantos MF; Martikainen IK; Nascimento TD; Love TM; DeBoer MD; Schambra HM; Bikson M; Zubieta JK; DaSilva AF
    PLoS One; 2014; 9(7):e102350. PubMed ID: 25029273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
    Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK
    Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.